Table 1 Antiretroviral Medications Purchased by the U.S. Medicaid Program from 1991 to 2005
Brand Name | Generic Name(s) | Manufacturer | Approval Date | Time to Approval |
|---|---|---|---|---|
Nucleoside Reverse Transcriptase Inhibitors (NRTIs) | ||||
Combivir | lamivudine and zidovudine | GlaxoSmithKline | 27-Sep-97 | 3.9 months |
Emtriva | emtricitabine, FTC | Gilead Sciences | 02-Jul-03 | 10 months |
Epivir | lamivudine, 3TC | GlaxoSmithKline | 17-Nov-95 | 4.4 months |
Epzicom | abacavir and lamivudine | GlaxoSmithKline | 02-Aug-04 | 10 months |
Hivid | zalcitabine, dideoxycytidine, ddC | Hoffmann-La Roche | 19-Jun-92 | 7.6 months |
Retrovir | zidovudine, azidothymidine, AZT, ZDV | GlaxoSmithKline | 19-Mar-87 | 3.5 months |
Trizivir | abacavir, zidovudine, and lamivudine | GlaxoSmithKline | 14-Nov-00 | 10.9 months |
Truvada | tenofovir disoproxil fumarate and emtricitabine | Gilead Sciences, Inc. | 02-Aug-04 | 5 months |
Videx EC | enteric coated didanosine, ddI EC | Bristol Myers-Squibb | 31-Oct-00 | 9 months |
Videx | didanosine, dideoxyinosine, ddI | Bristol Myers-Squibb | 9-Oct-91 | 6 months |
Viread | tenofovir disoproxil fumarate, TDF | Gilead | 26-Oct-01 | 5.9 months |
Zerit | stavudine, d4T | Bristol Myers-Squibb | 24-Jun-94 | 5.9 months |
Ziagen | abacavir sulfate, ABC | GlaxoSmithKline | 17-Dec-98 | 5.8 months |
Protease Inhibitors (PIs) | ||||
Agenerase | amprenavir, APV | GlaxoSmithKline | 15-Apr-99 | 6 months |
Aptivus | tipranavir, TPV | Boehringer Ingelheim | 22-Jun-05 | 6 months |
Crixivan | indinavir, IDV | Merck | 13-Mar-96 | 1.4 months |
Fortovase | saquinavir (no longer marketed) | Hoffmann-La Roche | 7-Nov-97 | 5.9 months |
Invirase | saquinavir mesylate, SQV | Hoffmann-La Roche | 6-Dec-95 | 3.2 months |
Kaletra | lopinavir and ritonavir, LPV/RTV | Abbott Laboratories | 15-Sep-00 | 3.5 months |
Lexiva | Fosamprenavir Calcium, FOS-APV | GlaxoSmithKline | 20-Oct-03 | 10 months |
Norvir | ritonavir, RTV | Abbott Laboratories | 1-Mar-96 | 2.3 months |
Reyataz | atazanavir sulfate, ATV | Bristol-Myers Squibb | 20-Jun-03 | 6 months |
Viracept | nelfinavir mesylate, NFV | Agouron Pharmaceuticals | 14-Mar-97 | 2.6 months |
Nonnucleoside Reverse Transcriptase Inhibitors (NNRTIs) | ||||
Rescriptor | delavirdine, DLV | Pfizer | 4-Apr-97 | 8.7 months |
Sustiva | efavirenz, EFV | Bristol Myers-Squibb | 17-Sep-98 | 3.2 months |
Viramune | nevirapine, NVP | Boehringer Ingelheim | 21-Jun-96 | 3.9 months |
Fusion Inhibitors | ||||
Fuzeon | enfuvirtide, T-20 | Hoffmann-La Roche & Trimeris | 13-Mar-03 | 6 months |